Literature DB >> 3262468

Spontaneous recovery of the decreased expression in vitro of interleukin 2 receptors in rheumatoid arthritis.

C Plater-Zyberk1, K A Rockett, R N Maini.   

Abstract

Peripheral blood mononuclear cells (PBM) from 11 patients with rheumatoid arthritis (RA) stimulated with 0.13 and 0.25 microgram/ml phytohaemagglutinin (PHA) for 3 days showed a depressed expression of interleukin 2 receptor (IL-2R) when compared with 14 normal controls (P less than 0.01). At these two doses of PHA a depressed lymphocyte proliferative response was also observed (P less than 0.01). However the kinetics of the response of the RA group differed from those of the control group. Whereas by day 6 IL-2R expression and lymphocyte proliferation in the control group was decreased compared with day 3, responses of the RA cells were increased. Following stimulation with the higher dose of PHA (1 microgram/ml) the kinetics of lymphocyte proliferation and IL-2R expression were equivalent in control and RA cultures. These results demonstrate that the impaired IL-2R expression and lymphocyte proliferation observed with sub-optimally stimulated PBM from RA patients is spontaneously reversed during prolonged culture and is consistent with the hypothesis that there is a lack of available IL-2 in the early stages of culture.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3262468      PMCID: PMC1541453     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

1.  Hyporesponsiveness of lymphocytes to virus antigens in rheumatoid arthritis.

Authors:  R E Wolf
Journal:  Arthritis Rheum       Date:  1978-03

2.  Lymphocyte reactivity to mitogens in subjects with systemic lupus erythematosus, rheumatoid arthritis and scleroderma.

Authors:  D A Horwitz; M A Garrett
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

3.  Ia+ T cells in synovial fluid and tissues of patients with rheumatoid arthritis.

Authors:  G R Burmester; D T Yu; A M Irani; H G Kunkel; R J Winchester
Journal:  Arthritis Rheum       Date:  1981-11

Review 4.  T-cell growth factor.

Authors:  K A Smith
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

5.  Interleukin 2 deficiency is a common feature of autoimmune mice.

Authors:  M J Dauphinée; S B Kipper; D Wofsy; N Talal
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

6.  Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus.

Authors:  J Alcocer-Varela; D Alarcón-Segovia
Journal:  J Clin Invest       Date:  1982-06       Impact factor: 14.808

7.  Studies of rheumatoid synovial fluid lymphocytes. II. A comparison of their behavior with blood mononuclear cells in the autologous mixed lymphocyte reaction and response to TCGF.

Authors:  R M Silver; D Redelman; N J Zvaifler
Journal:  Clin Immunol Immunopathol       Date:  1983-04

8.  Analysis of T cell function in autoimmune murine strains. Defects in production and responsiveness to interleukin 2.

Authors:  A Altman; A N Theofilopoulos; R Weiner; D H Katz; F J Dixon
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

9.  Transient expression of interleukin 2 receptors. Consequences for T cell growth.

Authors:  D A Cantrell; K A Smith
Journal:  J Exp Med       Date:  1983-12-01       Impact factor: 14.307

10.  T cell growth factor receptors. Quantitation, specificity, and biological relevance.

Authors:  R J Robb; A Munck; K A Smith
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

View more
  7 in total

1.  Interleukin-2 receptor gene polymorphism in Chinese patients with systemic lupus erythematosus.

Authors:  Chang-Hai Tsai; Chung-Ming Huang; Sui-Foon Lo; Lei Wan; Fuu-Jen Tsai
Journal:  Rheumatol Int       Date:  2006-02-25       Impact factor: 2.631

2.  Relations between surface expression of the interleukin-2 receptor and release of the soluble form of the receptor in cultured mononuclear cells from patients with rheumatoid arthritis or systemic lupus erythematosus.

Authors:  M Itoh; Y Goto; Y Ohta; Y Goto; H Ohashi
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

3.  Mechanism of a lymphocyte abnormality associated with HLA-B8/DR3 in clinically healthy individuals.

Authors:  S Hashimoto; C C McCombs; J P Michalski
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

4.  Anti-cardiolipin antibodies in infectious mononucleosis react with the membrane of activated lymphocytes.

Authors:  R Misra; P J Venables; C Plater-Zyberk; P F Watkins; R N Maini
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

5.  Lymphocyte surface marker expression in rheumatic diseases: evidence for prior activation of lymphocytes in vivo.

Authors:  M D Smith; P J Roberts-Thomson
Journal:  Ann Rheum Dis       Date:  1990-02       Impact factor: 19.103

6.  In vitro differentiation of peripheral blood T cells towards a type 2 phenotype is impaired in rheumatoid arthritis (RA).

Authors:  S Asselin; H Conjeaud; D Fradelizi; M Breban
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

7.  Chemoattraction of human blood T lymphocytes by interleukin-15.

Authors:  P C Wilkinson; F Y Liew
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.